Trials that use: Non-inferiority trial design
New to this method? Read the tutorial →
894 results
- Impact of Pillboxes on Medical Adherence: Complete Statistical AnalysisIndependent statistical analysis of Impact of Pillboxes on Medical Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03861845).
- Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: Complete Statistical AnalysisIndependent statistical analysis of Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02352103).
- Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IMPROVEIndependent statistical analysis of Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Improving ADHD Behavioral Care: Complete Statistical AnalysisIndependent statistical analysis of Improving ADHD Behavioral Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03628781).
- Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04342260).
- In Vivo Investigation of Initial Stages of Enamel Erosion: Complete Statistical AnalysisIndependent statistical analysis of In Vivo Investigation of Initial Stages of Enamel Erosion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02533466).
- Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Increasing Caregiver Engagement in Juvenile Drug Courts: Complete Statistical AnalysisIndependent statistical analysis of Increasing Caregiver Engagement in Juvenile Drug Courts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03051997).
- Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: primary endpoint results, effect estimate with confidence interval,…
- INDUMAIndependent statistical analysis of Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00207142).
- Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease: Complete Statistical AnalysisIndependent statistical analysis of Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Influenza Vaccine Post Allogeneic Transplant: Complete Statistical AnalysisIndependent statistical analysis of Influenza Vaccine Post Allogeneic Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215981).
- Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers: Complete Statistical AnalysisIndependent statistical analysis of Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02244918).
- Initial Performance of a Modified Daily Disposable Contact Lens: Complete Statistical AnalysisIndependent statistical analysis of Initial Performance of a Modified Daily Disposable Contact Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02694835).
- INTENSIVEIndependent statistical analysis of Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Investigation of a New 1-piece Convex Ostomy Product: Complete Statistical AnalysisIndependent statistical analysis of Investigation of a New 1-piece Convex Ostomy Product: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02043782).
- Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Investigation of New Intermittent Catheter Swelling Media in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Investigation of New Intermittent Catheter Swelling Media in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04633291).
- Investigation of the Safety and Effectiveness of a Trifocal IOL: Complete Statistical AnalysisIndependent statistical analysis of Investigation of the Safety and Effectiveness of a Trifocal IOL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176965).
- Investigation of Trunk Muscle Size and Function in Older Adults With Chronic Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Trunk Muscle Size and Function in Older Adults With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- INVIGORATEIndependent statistical analysis of Exacerbation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845728).
- IO Vancomycin in TSA: Complete Statistical AnalysisIndependent statistical analysis of IO Vancomycin in TSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05831774).
- IONMIndependent statistical analysis of Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00191282).
- IOPAIndependent statistical analysis of A Study for Patients With Diabetes Mellitus (IOPA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420095).
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: Complete Statistical AnalysisIndependent statistical analysis of Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02224625).
- Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): Complete Statistical AnalysisIndependent statistical analysis of Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Juno Perth Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Juno Perth Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02317042).
- KAREIndependent statistical analysis of Ketamine for Reduction of Alcoholic Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02649231).
- KARISMA2Independent statistical analysis of KARISMA2, a randomized phase 2 trial evaluating low-dose tamoxifen for mammographic density reduction, including its non-inferiority framework, Wald testing, multiplicity adjustment, results, safety, and statistical interpretation.
- KATE2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced…
- KEM-VOCIndependent statistical analysis of Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02434939).
- KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- La ComunidadIndependent statistical analysis of Latinos Combating Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831921).
- Large-scale Brain Organization During Cognitive Control in ADHD: Complete Statistical AnalysisIndependent statistical analysis of Large-scale Brain Organization During Cognitive Control in ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04349917).
- LASORIndependent statistical analysis of Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures: Complete Statistical AnalysisIndependent statistical analysis of Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00610701).
- LCIOADMT2Independent statistical analysis of Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LDP0114Independent statistical analysis of Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LEADER7Independent statistical analysis of Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LEAPSIndependent statistical analysis of Locomotor Experience Applied Post Stroke Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00243919).
- Less Infections for the Diabetic Foot: Complete Statistical AnalysisIndependent statistical analysis of Less Infections for the Diabetic Foot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03615807).
- Lesser Tuberosity Osteotomy for Subscapularis Repair: Complete Statistical AnalysisIndependent statistical analysis of Lesser Tuberosity Osteotomy for Subscapularis Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02762903).
- Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03940326).
- Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne: Complete Statistical AnalysisIndependent statistical analysis of Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne: primary endpoint results, effect estimate with…
- Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149887).
- Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…